Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaspan vs Phosex in severe chronic kidney disease
2005-002982-35Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of niacin in chronic kidney disease (CKD) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: TmPO4/GFR. Started Aug 2005; status: completed.
02
Drugs
niacin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-002982-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002982-35.